These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6727551)

  • 21. Substitution with buprenorphine in methadone- and morphine sulfate-dependent patients. Preliminary results.
    Bouchez J; Beauverie P; Touzeau D
    Eur Addict Res; 1998; 4 Suppl 1():8-12. PubMed ID: 9767200
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A preliminary evaluation of the effects of opioids on innate and adaptive human in vitro immune function.
    Boland JW; Foulds GA; Ahmedzai SH; Pockley AG
    BMJ Support Palliat Care; 2014 Dec; 4(4):357-67. PubMed ID: 24644198
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Opioid addicts at admission vs. slow-release oral morphine, methadone, and sublingual buprenorphine maintenance treatment participants.
    Giacomuzzi S; Kemmler G; Ertl M; Riemer Y
    Subst Use Misuse; 2006; 41(2):223-44. PubMed ID: 16393744
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discriminative stimulus effects of l-alpha-acetylmethadol (LAAM), buprenorphine and methadone in morphine-treated rhesus monkeys.
    Brandt MR; Cabansag SR; France CP
    J Pharmacol Exp Ther; 1997 Aug; 282(2):574-84. PubMed ID: 9262317
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fatal poisoning in drug addicts in the Nordic countries in 2012.
    Simonsen KW; Edvardsen HM; Thelander G; Ojanperä I; Thordardottir S; Andersen LV; Kriikku P; Vindenes V; Christoffersen D; Delaveris GJ; Frost J
    Forensic Sci Int; 2015 Mar; 248():172-80. PubMed ID: 25645132
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Flunitrazepam variably alters morphine, buprenorphine, and methadone lethality in the rat.
    Borron SW; Monier C; Risède P; Baud FJ
    Hum Exp Toxicol; 2002 Nov; 21(11):599-605. PubMed ID: 12507255
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The relationship of pharmacokinetics to pharmacological activity: morphine, methadone and naloxone.
    Berkowitz BA
    Clin Pharmacokinet; 1976; 1(3):219-30. PubMed ID: 13957
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Opioid pharmacokinetics in relation to their effects.
    Mather LE
    Anaesth Intensive Care; 1987 Feb; 15(1):15-22. PubMed ID: 2882700
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Opioid agonist and antagonist behavioural effects of buprenorphine.
    Leander JD
    Br J Pharmacol; 1983 Apr; 78(4):607-15. PubMed ID: 6850163
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discriminative stimulus effects of mu and kappa opioids in the pigeon: analysis of the effects of full and partial mu and kappa agonists.
    Picker MJ; Dykstra LA
    J Pharmacol Exp Ther; 1989 May; 249(2):557-66. PubMed ID: 2566680
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management.
    Mercadante S; Porzio G; Ferrera P; Fulfaro F; Aielli F; Verna L; Villari P; Ficorella C; Gebbia V; Riina S; Casuccio A; Mangione S
    Eur J Pain; 2008 Nov; 12(8):1040-6. PubMed ID: 18353696
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fast GC-MS method for the simultaneous screening of THC-COOH, cocaine, opiates and analogues including buprenorphine and fentanyl, and their metabolites in urine.
    Strano-Rossi S; Bermejo AM; de la Torre X; Botrè F
    Anal Bioanal Chem; 2011 Feb; 399(4):1623-30. PubMed ID: 21153585
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of tolerance to the analgesic activity of mu agonists after continuous infusion of morphine, meperidine or fentanyl in rats.
    Paronis CA; Holtzman SG
    J Pharmacol Exp Ther; 1992 Jul; 262(1):1-9. PubMed ID: 1625189
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of fatal poisonings by prescription opioids.
    Häkkinen M; Launiainen T; Vuori E; Ojanperä I
    Forensic Sci Int; 2012 Oct; 222(1-3):327-31. PubMed ID: 22884575
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transferring methadone-stabilized pregnant patients to buprenorphine using an immediate release morphine transition: an open-label exploratory study.
    Jones HE; Suess P; Jasinski DR; Johnson RE
    Am J Addict; 2006; 15(1):61-70. PubMed ID: 16449094
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Developmental responses to opioids reveals a lack of effect on stress-induced corticosterone levels in neonatal rats.
    Bailey CC; Kitchen I
    Br J Pharmacol; 1987 May; 91(1):119-25. PubMed ID: 3594070
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of effect of morphine-like analgesics on transmurally stimulated guinea-pig ileum.
    Fennessy MR; Heimans RL; Rand MJ
    Br J Pharmacol; 1969 Oct; 37(2):436-49. PubMed ID: 5348430
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of morphine, methadone, and fentanyl on mitochondria: A live cell imaging study.
    Nylander E; Zelleroth S; Nyberg F; Grönbladh A; Hallberg M
    Brain Res Bull; 2021 Jun; 171():126-134. PubMed ID: 33741459
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differences in the autoradiographic localization of labelled morphine-like analgesics in the mouse.
    Appelgren LE; Terenius L
    Acta Physiol Scand; 1973 Jun; 88(2):175-82. PubMed ID: 4202925
    [No Abstract]   [Full Text] [Related]  

  • 40. Innovations in agonist maintenance treatment of opioid-dependent patients.
    Haasen C; van den Brink W
    Curr Opin Psychiatry; 2006 Nov; 19(6):631-6. PubMed ID: 17012944
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.